Pricing
Not listed
Official monthly price not confirmed
- API
- Not confirmed
Research · Vendor site 2026-10-04
Atlas Discovery is an AI-native pharma company building foundation models of patient drug response and autonomous agents to repurpose medicines and run clinical trials efficiently. Public research highlights RepurposingBench benchmarks and blog posts on agent-driven drug development for long-tail diseases.
Drug developers and researchers exploring AI agents and foundation models for repurposing and trial design.
The public site is research-oriented with blog content and contact links rather than a commercial product storefront.
Atlas Discovery publishes work on patient response modeling and autonomous agents aimed at expanding economically viable drug programs.
What it can do
Unknown is different from unavailable. Each fact carries its own evidence.
| Capability | Value | Evidence | Checked |
|---|---|---|---|
| Company focus | Homepage describes foundation models of patient drug response and autonomous agents for repurposing and efficient trials. | Facts sourced | 2026-10-04 |
| Research publications | Site links blog research on RepurposingBench and agent-driven drug repurposing benchmarks. | Facts sourced | 2026-10-04 |
| Backing | Homepage notes backing by Y Combinator with contact and careers links. | Facts sourced | 2026-10-04 |
Understand the total cost
Pricing
Not listed
Official monthly price not confirmed
Elicit is an AI research assistant that searches academic and clinical literature, extracts data into tables, and runs Research Agent workflows for systematic reviews. Plans scale usage for reports, exports, and collaboration with optional enterprise controls.
Explore toolsupermemory provides memory and continual-learning infrastructure for AI agents, including storage, retrieval, connectors, and team billing through a credit-based console. Developers use it to keep long-lived context across chats, documents, and production workloads.
Explore toolFutureSearch provides AI forecasting and research agents with a public track record, letting users ask probability or numeric questions about future outcomes. Plans combine free starting credit with paid tiers that raise concurrent researcher limits and discount usage rates.
Explore toolThe practical questions
Atlas Discovery is an AI-native pharma company building foundation models of patient drug response and autonomous agents to repurpose medicines and run clinical trials efficiently. Public research highlights RepurposingBench benchmarks and blog posts on agent-driven drug development for long-tail diseases.
Not confirmed. This record does not confirm an ongoing free plan.
A listed monthly price has not been confirmed. See the plan cards for entitlements, billing commitments and seat minimums.
Not confirmed. API access and subscription access may have different terms; consult the linked sources.
The public site is research-oriented with blog content and contact links rather than a commercial product storefront.
No retained pricing changes yet. A current price alone does not establish a historical trend.
Reviewed vendor source
Read original source ↗Facts apply to the named version and check date. Send a sourced correction if something changed.